We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$19.9B
AUM Growth
+$3.15B
(+19%)
Cap. Flow
+$2.87B
Cap. Flow
% of AUM
14.37%
Top 10 Holdings %
Top 10 Hldgs %
18.32%
Holding
1,356
New
166
Increased
640
Reduced
325
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$179M |
| 2 |
Amazon
AMZN
|
+$121M |
| 3 |
Alibaba
BABA
|
+$111M |
| 4 |
Merck
MRK
|
+$94.9M |
| 5 |
Comcast
CMCSA
|
+$78.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$88.1M |
| 2 |
Cisco
CSCO
|
+$82.5M |
| 3 |
NextEra Energy
NEE
|
+$74.9M |
| 4 |
Union Pacific
UNP
|
+$52M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$46.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Healthcare | 17.64% |
| 3 | Financials | 13.64% |
| 4 | Communication Services | 10.78% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCC
651
WESCO International
WCC
$17.7B
| $1.81M | 0.01% |
35,900
+28,892
| +412% | +$1.51M |
|
652
Annaly Capital Management
NLY
$17.4B
| $1.81M | 0.01% |
48,479
+26,019
| +116% | +$991K |
|
653
Healthpeak Properties
DOC
$14.8B
| $1.79M | 0.01% |
54,573
-121,456
| -69% | -$3.78M |
|
|
PTLA
654
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.79M | 0.01% |
67,000
+24,246
| +57% | +$760K |
|
655
W.R. Berkley
WRB
$26.6B
| $1.77M | 0.01% |
59,974
-14,428
| -19% | -$395K |
|
656
Genuine Parts
GPC
$18.7B
| $1.77M | 0.01% |
16,666
+1,738
| +12% | +$180K |
|
657
Ironwood Pharmaceuticals
IRWD
$714M
| $1.76M | 0.01% |
163,300
+135,889
| +496% | +$1.52M |
|
658
CarMax
KMX
$8.26B
| $1.76M | 0.01% |
19,730
+4,533
| +30% | +$355K |
|
|
CXO
659
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.75M | 0.01% |
16,475
-140,086
| -89% | -$15.1M |
|
660
Microchip Technology
MCHP
$46B
| $1.74M | 0.01% |
38,198
-83,678
| -69% | -$3.72M |
|
661
Fortune Brands Innovations
FBIN
$6.06B
| $1.73M | 0.01% |
35,295
+17,904
| +103% | +$797K |
|
|
CYBR
662
DELISTED
CyberArk
CYBR
| $1.72M | 0.01% |
13,556
+11,711
| +635% | +$1.48M |
|
663
Globant
GLOB
$1.61B
| $1.71M | 0.01% |
17,250
-4,400
| -20% | -$383K |
|
664
Sabre
SABR
$835M
| $1.71M | 0.01% |
75,651
+59,818
| +378% | +$1.28M |
|
665
Equity Lifestyle Properties
ELS
$12.6B
| $1.7M | 0.01% |
27,708
+5,324
| +24% | +$315K |
|
666
Teva Pharmaceuticals
TEVA
$41.2B
| $1.69M | 0.01% |
185,882
+77,895
| +72% | +$939K |
|
|
ITCI
667
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.67M | 0.01% |
131,400
+42,500
| +48% | +$545K |
|
668
Medpace
MEDP
$16.5B
| $1.67M | 0.01% |
26,000
+10,000
| +63% | +$576K |
|
669
Supernus Pharmaceuticals
SUPN
$2.77B
| $1.66M | 0.01% |
51,800
+20,100
| +63% | +$689K |
|
670
Brown-Forman Class B
BF.B
$13.1B
| $1.66M | 0.01% |
29,009
+10,917
| +60% | +$583K |
|
671
Cenovus Energy
CVE
$52.1B
| $1.65M | 0.01% |
186,704
-61,000
| -25% | -$550K |
|
672
NOV
NOV
$7B
| $1.65M | 0.01% |
75,150
+33,540
| +81% | +$810K |
|
673
SolarEdge
SEDG
$1.95B
| $1.65M | 0.01% |
+27,000
| New | +$1.36M |
|
674
Bread Financial
BFH
$4.38B
| $1.65M | 0.01% |
14,768
-16,895
| -53% | -$2.04M |
|
675
A.O. Smith
AOS
$8.7B
| $1.64M | 0.01% |
34,982
-38,881
| -53% | -$1.91M |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2019 Portfolio in Review
As of Q2 2019, DekaBank Deutsche Girozentrale held 1,356 positions worth $19.9B, up 19% from $16.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
DekaBank Deutsche Girozentrale deployed $2.87B of net new capital in Q2 2019, opening 166 new positions and adding to 640 existing holdings. Its largest new stake was Alcon: 743,373 shares worth $45.4M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was TSMC, an estimated $88.1M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2019 buy was Alcon: 743,373 shares worth $45.4M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q2 2019, an estimated $179M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2019 reduction was TSMC, cutting an estimated $88.1M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q2 2019, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $19.9B portfolio in Q2 2019.
- DekaBank Deutsche Girozentrale opened 166 new positions and closed 204 in Q2 2019.
- DekaBank Deutsche Girozentrale's portfolio value rose 19% quarter-over-quarter to $19.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2019, filed 1 Aug 2019.